Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Kapustina, V. Fedorova, A. Voronkova, N. Kapranov (Moscow, Russian Federation). Long-term treatment with corticosteroids and bone mineral density in patients with cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 1240

Member's Comments

No comment yet.

Related content which might interest you: Low bone mineral density in children with cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 388s Year: 2007 Long-term effects of corticosteroid use on bone mineral density in asthmatic children Source: Breathe 2008; 5: 70-71 Year: 2008 Low-dose chest CT for bone mineral density in pediatric patients with cystic fibrosis Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Diagnosis and management of cystic fibrosis related low bone mineral density Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=150 Year: 2006 Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R) Source: Eur Respir J 2002; 19: 1058-1063 Year: 2002 Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Bone density in adult patients with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 265s Year: 2002 Changes in bone mineral density of lumbar spine during one year in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001 Undertreatment of loss of bone mineral density in patients with COPD who were referred for pulmonary rehabilitation Source: Eur Respir J 2006; 28: Suppl. 50, 71s Year: 2006 Reduced bone density in children and adolescents with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 621s Year: 2005 Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor Source: Eur Respir J 2005; 25: 54-61 Year: 2005 The evaluation of bone density in the patients with bronchial asthma treated with glucocorticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Loss of bone mineral density in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Primary care management of COPD Year: 2007 Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 A comparison of bone mineral density in elderly patients with COPD and bronchial asthma Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Effects of long term used inhaled corticosteroids on growth and bone mineral density in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 Bone mineral density and inhaled budesonide – a systematic review of long-term treatment in children and adults Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Bone mineral density reduction and long term use of inhaled corticosteroids Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008 Bone density in cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 388s Year: 2007 Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity? Source: Eur Respir J 2005; 26: Suppl. 49, 526s Year: 2005